Article
Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes.
Current biology : CB - 14 Jan 1999
Durant S T, Morris M M, Illand M, McKay H J, McCormick C, Hirst G L, Borts R H, Brown R
Abstract excerpt
Mismatch repair (MMR) proteins repair mispaired DNA bases and have an important role in maintaining the integrity of the genome [1]. Loss of MMR has been correlated with resistance to a variety of DNA-damaging agents, including many anticancer drugs [2]. How loss of MMR leads to resistance is not understood, but is proposed to be due to loss of futile MMR activity and/or replication stalling [3] [4]. We report...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
